Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy [10]

American Journal of Gastroenterology

Volumn 97, Issue 1, 2002, Pages 212-214

  Kurihara, Takeshi ^a   Maeda, Atsushi ^b   Shigemoto, Mutsuo ^b   Yamashita, Katsuko ^b   Hashimoto, Etsuko ^b  

^a Tokyo Women s Medical University   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BEZAFIBRATE; GAMMA GLUTAMYLTRANSFERASE; URSODEOXYCHOLIC ACID;

ADULT; AGED; CASE REPORT; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; LETTER; LIVER FUNCTION; LONG TERM CARE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0036143517     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03975-2     Document Type: Letter

References (11)

1. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
2. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis
3. Bezafibrate may have a beneficial effect in precirrhotic primary biliary cirrhosis
4. Effect of bezafibrate in the treatment of primary biliary cirrhosis
5. Bezafibrate in the treatment of primary biliary cirrhosis
6. Fatty acids, eicosanoids, and hypolipemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator dependent-receptor ligand assay
7. 4 pathway to inflammation control
8. Activation of human aortic smooth-muscle cells inhibited by PPARα but not by PPARγ activators
9. Inhibition of VCAM-l expression in endothelial cells by reconstituted high density lipoproteins
10. Fibrates induce MDR 2 gene expression and biliary phospholipid secretion in the mouse
11. Study of effectiveness of bezafibrate in the treatment of chronic hepatitis C